Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
The greatest increase was among 50- to 69-year-olds.
Thirty-six future leaders in hepatology were selected to receive awards this year.
Do you use the internet for information about hepatitis, liver disease, and your health? If so, here are some things you’ll want to know.
National guidelines have indicated that Blacks who qualify for the eight-week hep C treatment should nevertheless take 12 weeks.
Highlights from the 2017 Liver Meeting, presented by the American Association for the Study of Liver Diseases.
A 50-year-old woman with NAFLD has about the same cardiovascular risk as a 67-year-old woman without fatty liver disease.
Today’s highlights from the 2016 Liver Meeting look at hepatitis C treatment, the heart, and insulin resistance.
A summary of some of the latest hepatitis C regimens presented at the 2016 Liver Meeting.
Research from the 2016 Liver Meeting
The latest research from the 2016 Liver Meeting
Highlights from the 2016 Liver Meeting
The annual meeting of the American Association for the Study of Liver Diseases is now in sessions; watch for updates.
Tips for getting and paying for Epclusa, the newest hepatitis C treatment approved by the FDA.
What new therapies are being developed by the major players in hepatitis C pharmaceuticals?
By the end of 2015, U.S. health care spending was expected to grow nearly 6 percent from 2014.
If hep C treatment decisions are based solely on the drug manufacturers’ FDA-approved package information, your options would be limited.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.